BiotechTube
Home/Pipeline/Pipeline of Complex Generics

Pipeline of Complex Generics

Various

DevelopmentActive

Key Facts

Indication
Various
Phase
Development
Status
Active
Company
Mayne Pharma Group

About Mayne Pharma Group

Mayne Pharma Group is an Australian specialty pharmaceutical company with a dual focus on developing novel drug delivery technologies and commercializing a portfolio of branded and generic products. The company has built a substantial US commercial platform through acquisitions and leverages its in-house development and manufacturing capabilities. Its strategic direction centers on expanding its women's health franchise, optimizing its commercial portfolio, and advancing its pipeline of complex generic and 505(b)(2) products.

View full company profile

Therapeutic Areas

Women's HealthDermatologyCNSAnti-infectivesCardiovascular

Other Various Drugs

DrugCompanyPhase
Biosimilar ProgramsRichter GedeonPhase 3
Oligonucleotide APIsBachemClinical/Commercial
Novel Plasma-derived TherapiesTiantan BioPre-clinical
Complex Injectable Generics PipelineAmphastar PharmaceuticalsANDA Filed / Development
Generic PortfolioStrides PharmaApproved
New Product LaunchesFDC IndiaDevelopment/Filing
Generic Products PortfolioCelon PharmaApproved/Commercial
New Generic Filings (e.g., for US/EU)Bliss GVS PharmaRegulatory Review
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved